https://www.selleckchem.com/products/jdq443.html
Although multiple baseline randomisation strengthens the study, it lacked a control arm and blind assessments. CONCLUSIONS iMAPS appears a feasible and acceptable treatment for psychosis, and further evaluation is indicated.This case report highlights the risk of development of Neuroleptic Malignant-Like Syndrome secondary to withdrawal of procyclidine with brief withdrawal of L-dopa and long-term typical antipsychotic depot. The patient responded to reintroduction of procyclidine, sedation and supportive treatment. The mechanism and man
Like
Comment
Share
